Clinical Research Directory
Browse clinical research sites, groups, and studies.
Watermelon/UBIQuinone Study
Sponsor: University of California, San Francisco
Summary
The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.
Official title: Watermelon/UBIQuinone Study (WUBI-Q Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2021-11-15
Completion Date
2026-06-30
Last Updated
2025-07-14
Healthy Volunteers
No
Conditions
Interventions
coenzyme Q10
Participants will take 800-1200 mg of coenzyme Q10 capsule per day
Watermelon diet
Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week
Usual Diet
Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet
Placebo
Participants will be asked to take 800-1200 mg of a placebo capsule per day
Locations (1)
University of California San Francisco
San Francisco, California, United States